Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant

Table 1

Jecti; S/NS/N	Baseline		4 weeks		8 weeks		12 weeks		16 weeks		20 weeks
	CRT	BCVA; logMAR	CRT	BCVA; logMAR	CRT	BCVA; logMAR	CRT	BCVA; logMAR	CRT	BCVA; logMAR	CRT	BCVA
1	662	0.5	264	0.3	275	0.1	260	0.1	276	0.1	456	0.5
2	745	0.5	255	0.4	253	0.2	238	0.2	647	0.5	715	0.5
3	579	0.5	328	0.5	287	1.2	Posterior capsule cataract occurred
4	757	1.1	320	0.5	231	0.5	276	0.5	456	0.7	560	1.0
5	657	1.0	272	0.5	268	1.0	449	0.7	550	1.0	603	1.0
6	703	1.2	257	1.1	237	1.0	223	1.0	535	1.0	625	1.1
7	529	1.1	228	1.0	220	1.0	259	0.5	399	0.7	444	1.0
8	426	0.5	212	0.5	214	0.2	239	0.3	233	0.3	243	0.4

BCVA: best corrected visual acuity; CRT: central retinal thickness in μm; S/N: serial number of injection.